ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q2 2017. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $8,000 | +33.3% | 2,500 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $6,000 | +20.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,000 | -37.5% | 2,500 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $8,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $8,000 | +33.3% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $6,000 | +50.0% | 2,500 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $4,000 | +33.3% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $3,000 | +50.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $2,000 | -33.3% | 2,500 | 0.0% | 0.00% | -66.7% |
Q4 2015 | $3,000 | -72.7% | 2,500 | +150.0% | 0.00% | -40.0% |
Q3 2015 | $11,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |